The latest notes bring Bay City's total investment in the company to , SynGen's President and Chief Executive Officer. "The latest financing will allow us to make our first sales of the SynGenXa -1000 System to cord blood banks, and to continue to commercialize the SynGenXa -Lab and CellWashPRO devices for stem cell processing customers.
http://ift.tt/1pDxgre
http://ift.tt/1pDxgre
No comments:
Post a Comment